IFNγ/IL-10 Co-producing Cells Dominate the CD4 Response to Malaria in Highly Exposed Children

PLoS Pathogens

Volumn 10, Issue 1, 2014, Pages

  Jagannathan, Prasanna ^a   Eccles James, Ijeoma ^a   Bowen, Katherine ^a   Nankya, Felistas ^b   Auma, Ann ^b   Wamala, Samuel ^b   Ebusu, Charles ^b   Muhindo, Mary K ^b   Arinaitwe, Emmanuel ^b   Briggs, Jessica ^a   Greenhouse, Bryan ^a   Tappero, Jordan W ^c   Kamya, Moses R ^d   Dorsey, Grant ^a   Feeney, Margaret E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INFECTIOUS DISEASES RESEARCH COLLABORATION   (Uganda)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IFNG PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

BLOOD; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL TRIAL; ERYTHROCYTE; FEMALE; HUMAN; IMMUNOLOGY; MALARIA; MALE; METABOLISM; MULTICENTER STUDY; PARASITOLOGY; PATHOLOGY; PRESCHOOL CHILD; UGANDA;

CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-10; MALARIA; MALE; TUMOR NECROSIS FACTOR-ALPHA; UGANDA;

EID: 84893737751     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003864     Document Type: Article

References (94)

1. Langhorne J, Ndungu FM, Sponaas AM, Marsh K, (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725-732.
2. Marsh K, Kinyanjui S, (2006) Immune effector mechanisms in malaria. Parasite Immunol 28: 51-60.
3. Tran TM, Li S, Doumbo S, Doumtabe D, Huang CY, et al. (2013) An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis 57: 40-47.
4. Deloron P, Chougnet C, (1992) Is immunity to malaria really short-lived? Parasitol Today 8: 375-378.
5. Di Perri G, Solbiati M, Vento S, De Checchi G, Luzzati R, et al. (1994) West African Immigrants and New Patterns of Malaria Imported to North Eastern Italy. Journal of Travel Medicine 1: 147-151.
6. Barry AE, Schultz L, Buckee CO, Reeder JC, (2009) Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum. PLoS ONE 4: e8497.
7. Adkins B, (1999) T-cell function in newborn mice and humans. Immunol Today 20: 330-335.
8. Pass RF, Stagno S, Britt WJ, Alford CA, (1983) Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 148: 953-961.
9. Adkins B, Leclerc C, Marshall-Clarke S, (2004) Neonatal adaptive immunity comes of age. Nat Rev Immunol 4: 553-564.
10. Holt PG, (2003) Functionally mature virus-specific CD8(+) T memory cells in congenitally infected newborns: proof of principle for neonatal vaccination? J Clin Invest 111: 1645-1647.
11. Wilson CB, Lewis DB, (1990) Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev Infect Dis 12 (Suppl 4) (): S410-420.
12. Wilson CB, Lewis DB, English BK, (1991) T cell development in the fetus and neonate. Adv Exp Med Biol 310: 17-27.
13. Ho M, Webster HK, Looareesuwan S, Supanaranond W, Phillips RE, et al. (1986) Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis 153: 763-771.
14. Plebanski M, Flanagan KL, Lee EA, Reece WH, Hart K, et al. (1999) Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. Immunity 10: 651-660.
15. Walther M, Tongren JE, Andrews L, Korbel D, King E, et al. (2005) Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23: 287-296.
16. Bejon P, Mwacharo J, Kai O, Todryk S, Keating S, et al. (2007) The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J Immunol 179: 4193-4201.
17. Butler NS, Moebius J, Pewe LL, Traore B, Doumbo OK, et al. (2012) Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 13: 188-195.
18. Freitas do Rosario AP, Lamb T, Spence P, Stephens R, Lang A, et al. (2012) IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol 188: 1178-1190.
19. Freitas do Rosario AP, Langhorne J, (2012) T cell-derived IL-10 and its impact on the regulation of host responses during malaria. Int J Parasitol 42: 549-555.
20. Jagannathan P, Muhindo MK, Kakuru A, Arinaitwe E, Greenhouse B, et al. (2012) Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda. Malar J 11: 435.
21. Roca-Feltrer A, Kwizombe CJ, Sanjoaquin MA, Sesay SS, Faragher B, et al. (2012) Lack of decline in childhood malaria, Malawi, 2001-2010. Emerging infectious diseases 18: 272-278.
22. Trape JF, Tall A, Diagne N, Ndiath O, Ly AB, et al. (2011) Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infectious Diseases 11: 925-932.
23. Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, et al. (1987) Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330: 664-666.
24. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, et al. (1989) Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341: 323-326.
25. Rodrigues M, Nussenzweig RS, Zavala F, (1993) The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology 80: 1-5.
26. Tsuji M, Bergmann CC, Takita-Sonoda Y, Murata K, Rodrigues EG, et al. (1998) Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. J Virol 72: 6907-6910.
27. Stephens R, Albano FR, Quin S, Pascal BJ, Harrison V, et al. (2005) Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 106: 1676-1684.
28. Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, et al. (2008) Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci U S A 105: 14017-14022.
29. Overstreet MG, Cockburn IA, Chen YC, Zavala F, (2008) Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol Rev 225: 272-283.
30. Stephens R, Langhorne J, (2010) Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria. PLoS Pathog 6: e1001208.
31. Nussenzweig RS, Vanderberg J, Most H, Orton C, (1967) Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 216: 160-162.
32. Clyde DF, Most H, McCarthy VC, Vanderberg JP, (1973) Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 266: 169-177.
33. Hoffman SL, Doolan DL, (2000) Malaria vaccines-targeting infected hepatocytes. Nat Med 6: 1218-1219.
34. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, et al. (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361: 468-477.
35. Friesen J, Silvie O, Putrianti ED, Hafalla JC, Matuschewski K, et al. (2010) Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med 2: 40ra49.
36. Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, et al. (2011) Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377: 1770-1776.
37. Reece WH, Pinder M, Gothard PK, Milligan P, Bojang K, et al. (2004) A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med 10: 406-410.
38. Todryk SM, Bejon P, Mwangi T, Plebanski M, Urban B, et al. (2008) Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans. PLoS ONE 3: e2027.
39. Kurtis JD, Hollingdale MR, Luty AJ, Lanar DE, Krzych U, et al. (2001) Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Trends Parasitol 17: 219-223.
40. Hoffman SL, Oster CN, Mason C, Beier JC, Sherwood JA, et al. (1989) Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol 142: 1299-1303.
41. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, et al. (1999) Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 179: 980-988.
42. Moormann AM, Sumba PO, Chelimo K, Fang H, Tisch DJ, et al. (2013) Humoral and Cellular Immunity to Plasmodium falciparum Merozoite Surface Protein 1 and Protection From Infection With Blood-Stage Parasites. J Infect Dis 208: 149-158.
43. D'Ombrain MC, Robinson LJ, Stanisic DI, Taraika J, Bernard N, et al. (2008) Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 47: 1380-1387.
44. McCall MB, Hopman J, Daou M, Maiga B, Dara V, et al. (2010) Early interferon-gamma response against Plasmodium falciparum correlates with interethnic differences in susceptibility to parasitemia between sympatric Fulani and Dogon in Mali. J Infect Dis 201: 142-152.
45. Bejon P, Warimwe G, Mackintosh CL, Mackinnon MJ, Kinyanjui SM, et al. (2009) Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun 77: 1917-1923.
46. Greenhouse B, Ho B, Hubbard A, Njama-Meya D, Narum DL, et al. (2011) Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis 204: 19-26.
47. Douek DC, Roederer M, Koup RA, (2009) Emerging concepts in the immunopathogenesis of AIDS. Annual Review of Medicine 60: 471-484.
48. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nature medicine 13: 843-850.
49. Anderson CF, Oukka M, Kuchroo VJ, Sacks D, (2007) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204: 285-297.
50. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, et al. (2007) Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
51. Olotu A, Moris P, Mwacharo J, Vekemans J, Kimani D, et al. (2011) Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01(E) and Protection against P falciparum Clinical Malaria. PLoS ONE 6: e25786.
52. Walther M, Jeffries D, Finney OC, Njie M, Ebonyi A, et al. (2009) Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog 5: e1000364.
53. Zhang G, Manaca MN, McNamara-Smith M, Mayor A, Nhabomba A, et al. (2012) Interleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children. Infect Immun 80: 2316-2322.
54. Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF,et al. (2011) Live Attenuated Malaria Vaccine Designed to Protect through Hepatic CD8+ T Cell Immunity. Science.
55. Olotu A, Moris P, Mwacharo J, Vekemans J, Kimani D, et al. (2011) Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria. PLoS ONE 6: e25786.
56. Cope A, Le Friec G, Cardone J, Kemper C, (2011) The Th1 life cycle: molecular control of IFN-gamma to IL-10 switching. Trends in Immunology 32: 278-286.
57. O'Garra A, Vieira P, (2007) T(H)1 cells control themselves by producing interleukin-10. Nature reviews Immunology 7: 425-428.
58. Wenisch C, Parschalk B, Narzt E, Looareesuwan S, Graninger W, (1995) Elevated serum levels of IL-10 and IFN-gamma in patients with acute Plasmodium falciparum malaria. Clinical Immunology and Immunopathology 74: 115-117.
59. Peyron F, Burdin N, Ringwald P, Vuillez JP, Rousset F, et al. (1994) High levels of circulating IL-10 in human malaria. Clinical and experimental immunology 95: 300-303.
60. Wilson NO, Bythwood T, Solomon W, Jolly P, Yatich N, et al. (2010) Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women. Infectious Diseases in Obstetrics and Gynecology 2010: pii: 317430.
61. Pinzon-Charry A, Woodberry T, Kienzle V, McPhun V, Minigo G, et al. (2013) Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria. J Exp Med 210: 1635-1646.
62. O'Connor RA, Jenson JS, Osborne J, Devaney E, (2003) An enduring association? Microfilariae and immunosuppression [correction of immunosupression] in lymphatic filariasis. Trends Parasitol 19: 565-570.
63. Steel C, Guinea A, McCarthy JS, Ottesen EA, (1994) Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens. Lancet 343: 890-893.
64. Wammes LJ, Hamid F, Wiria AE, Wibowo H, Sartono E, et al. (2012) Regulatory T cells in human lymphatic filariasis: stronger functional activity in microfilaremics. PLoS Neglected Tropical Diseases 6: e1655.
65. Maizels RM, Yazdanbakhsh M, (2003) Immune regulation by helminth parasites: cellular and molecular mechanisms. Nature reviews Immunology 3: 733-744.
66. McNeil AC, Shupert WL, Iyasere CA, Hallahan CW, Mican JA, et al. (2001) High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. Proc Natl Acad Sci U S A 98: 13878-13883.
67. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, et al. (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194: 1395-1406.
68. Haringer B, Lozza L, Steckel B, Geginat J, (2009) Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood. J Exp Med 206: 1009-1017.
69. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, et al. (2000) IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105: 1317-1325.
70. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, et al. (2008) In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 205: 2887-2898.
71. O'Garra A, Vieira P, (2007) T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7: 425-428.
72. Li C, Corraliza I, Langhorne J, (1999) A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect Immun 67: 4435-4442.
73. Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, et al. (1998) Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect Immun 66: 6040-6044.
74. Flanagan KL, Plebanski M, Odhiambo K, Sheu E, Mwangi T, et al. (2006) Cellular reactivity to the p. Falciparum protein trap in adult kenyans: novel epitopes, complex cytokine patterns, and the impact of natural antigenic variation. Am J Trop Med Hyg 74: 367-375.
75. Gitau EN, Tuju J, Stevenson L, Kimani E, Karanja H, et al. (2012) T-cell responses to the DBLalpha-tag, a short semi-conserved region of the Plasmodium falciparum membrane erythrocyte protein 1. PLoS ONE 7: e30095.
76. Roetynck S, Olotu A, Simam J, Marsh K, Stockinger B, et al. (2013) Phenotypic and functional profiling of CD4 T cell compartment in distinct populations of healthy adults with different antigenic exposure. PLoS ONE 8: e55195.
77. Freitas do Rosario AP, Langhorne J, (2012) T cell-derived IL-10 and its impact on the regulation of host responses during malaria. International Journal for Parasitology 42: 549-555.
78. Metenou S, Dembele B, Konate S, Dolo H, Coulibaly YI, et al. (2011) Filarial infection suppresses malaria-specific multifunctional Th1 and Th17 responses in malaria and filarial coinfections. Journal of immunology 186: 4725-4733.
79. Brustoski K, Moller U, Kramer M, Petelski A, Brenner S, et al. (2005) IFN-gamma and IL-10 mediate parasite-specific immune responses of cord blood cells induced by pregnancy-associated Plasmodium falciparum malaria. Journal of immunology 174: 1738-1745.
80. Brockman MA, Kwon DS, Tighe DP, Pavlik DF, Rosato PC, et al. (2009) IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114: 346-356.
81. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, et al. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12: 1301-1309.
82. Depinay N, Franetich JF, Gruner AC, Mauduit M, Chavatte JM, et al. (2011) Inhibitory effect of TNF-alpha on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations. PLoS ONE 6: e17464.
83. Nussler A, Pied S, Goma J, Renia L, Miltgen F, et al. (1991) TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6. International Immunology 3: 317-321.
84. Katrak S, Gasasira A, Arinaitwe E, Kakuru A, Wanzira H, et al. (2009) Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children. Malaria Journal 8: 272.
85. Sandison TG, Homsy J, Arinaitwe E, Wanzira H, Kakuru A, et al. (2011) Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. BMJ 342: d1617.
86. Vora N, Homsy J, Kakuru A, Arinaitwe E, Wanzira H, et al. (2010) Breastfeeding and the risk of malaria in children born to HIV-infected and uninfected mothers in rural Uganda. Journal of Acquired Immune Deficiency Syndromes 55: 253-261.
87. Arinaitwe E, Sandison TG, Wanzira H, Kakuru A, Homsy J, et al. (2009) Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 49: 1629-1637.
88. (2010) Uganda Clinical Guidelines 2010. National Guidelines on Management of Common Conditions. Kampala, Uganda: Uganda Ministry of Health.
89. Wipasa J, Okell L, Sakkhachornphop S, Suphavilai C, Chawansuntati K, et al. (2011) Short-lived IFN-gamma effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS pathogens 7: e1001281.
90. Horowitz A, Newman KC, Evans JH, Korbel DS, Davis DM, et al. (2010) Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J Immunol 184: 6043-6052.
91. Maecker HT, Trotter J, (2006) Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry Part A 69: 1037-1042.
92. Lamoreaux L, Roederer M, Koup R, (2006) Intracellular cytokine optimization and standard operating procedure. Nat Protoc 1: 1507-1516.
93. McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, et al. (2008) Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach. Cytometry Part A 73: 400-410.
94. Roederer M, Nozzi JL, Nason MX, (2011) SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytometry Part A [Epub ahead of print].